Rinaldi; Gianluca
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rinaldi; Gianluca.The latest application filed is for "liquid pharmaceutical composition".
- Rinaldi; Gianluca - Monterotondo IT
| Patent | Date |
|---|---|
| Liquid pharmaceutical composition Grant 11,197,930 - Rinaldi , et al. December 14, 2 | 2021-12-14 |
| Liquid Pharmaceutical Composition App 20210322551 - Rinaldi; Gianluca ; et al. | 2021-10-21 |
| Liquid Pharmaceutical Composition App 20210308262 - Rinaldi; Gianluca ; et al. | 2021-10-07 |
| Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody Avelumab Grant 11,058,769 - Rinaldi , et al. July 13, 2 | 2021-07-13 |
| Liquid Pharmaceutical Composition App 20210196824 - Rinaldi; Gianluca ; et al. | 2021-07-01 |
| Liquid Pharmaceutical Composition App 20210121566 - Rinaldi; Gianluca ; et al. | 2021-04-29 |
| Aqueous Pharmaceutical Formulation Comprising Anti-pd-l1 Antibody Avelumab App 20210100903 - RINALDI; Gianluca ; et al. | 2021-04-08 |
| Liquid pharmaceutical composition of etanercept with lysine and proline Grant 10,959,939 - Freitag , et al. March 30, 2 | 2021-03-30 |
| Liquid Pharmaceutical Composition App 20210030871 - Rinaldi; Gianluca ; et al. | 2021-02-04 |
| Liquid Pharmaceutical Composition App 20210023215 - Rinaldi; Gianluca ; et al. | 2021-01-28 |
| Liquid pharmaceutical composition Grant 10,772,961 - Rinaldi , et al. Sept | 2020-09-15 |
| Liquid pharmaceutical composition Grant 10,729,769 - Rinaldi , et al. | 2020-08-04 |
| Liquid Pharmaceutical Composition App 20200155677 - Rinaldi; Gianluca ; et al. | 2020-05-21 |
| Liquid Pharmaceutical Composition App 20200085948 - Rinaldi; Gianluca ; et al. | 2020-03-19 |
| Aqueous Anti-pd-l1 Antibody Formulation App 20200016267 - Rinaldi; Gianluca ; et al. | 2020-01-16 |
| Liquid Pharmaceutical Composition App 20200016268 - Rinaldi; Gianluca ; et al. | 2020-01-16 |
| Adalimumab formulations Grant 10,493,152 - Rinaldi , et al. De | 2019-12-03 |
| Liquid pharmaceutical composition Grant 10,426,833 - Rinaldi , et al. October 1, 2 | 2019-10-01 |
| Liquid pharmaceutical composition Grant 10,426,832 - Rinaldi , et al. October 1, 2 | 2019-10-01 |
| Aqueous Pharmaceutical Formulation Comprising Anti-pd-l1 Antibody Avelumab App 20180369377 - RINALDI; Gianluca ; et al. | 2018-12-27 |
| Liquid Pharmaceutical Composition App 20180296674 - Rinaldi; Gianluca ; et al. | 2018-10-18 |
| Liquid Pharmaceutical Composition App 20170348225 - FREITAG; Angelika ; et al. | 2017-12-07 |
| Liquid Pharmaceutical Composition App 20170196974 - Rinaldi; Gianluca ; et al. | 2017-07-13 |
| Liquid Pharmaceutical Composition App 20170189527 - Rinaldi; Gianluca ; et al. | 2017-07-06 |
| Liquid Pharmaceutical Composition App 20170182162 - Rinaldi; Gianluca ; et al. | 2017-06-29 |
| Formulations for TACI-immunoglobulin fusion proteins Grant 8,637,021 - Del Rio , et al. January 28, 2 | 2014-01-28 |
| Formulations For Taci-immunoglobulin Fusion Proteins App 20100297122 - Del Rio; Alessandra ; et al. | 2010-11-25 |
| Taci-immunoglobulin Fusion Proteins For Treatment Of Optic Neuritis App 20100239580 - Del Rio; Alessandra ; et al. | 2010-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 